Influence of functional genetic polymorphism (-590C/T) in non-small cell lung cancer (NSCLC) development: The paradoxal role of IL-4

Gene

Volumn 504, Issue 1, 2012, Pages 111-115

  Gomes, Mónica ^a,b,d   Coelho, Ana ^a,c,d   Araújo, António ^a,b   Teixeira, Ana Luísa ^a,b   Catarino, Raquel ^a,c   Medeiros, Rui ^a,b,d  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c University of Porto   (Portugal)

^d LPCC   (Portugal)

Author keywords

Cancer susceptibility; Interleukin 4; Non small cell lung cancer; Polymorphism

Indexed keywords

INTERLEUKIN 4;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER GROWTH; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; EPIDERMOID TUMOR; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-4; LUNG; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROMOTER REGIONS, GENETIC;

EID: 84862309386     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.05.008     Document Type: Article

References (40)

1. Alberg A.J., Brock M.V., Samet J.M. Epidemiology of lung cancer: looking to the future. J. Clin. Oncol. 2005, 23:3175-3185.
2. Attia J., Thakkinstian A., McElduff P., Milne E., Dawson S., et al. Detecting Genotyping Error Using Measures of Degree of Hardy-Weinberg Disequilibrium John Attia, University of Newcastle. Stat Appl Genet Mol Biol 9 2010, Article 5.
3. Anovazzi G., Kim Y.J., Viana A.C., Curtis K.M., Orrico S.R., et al. Polymorphisms and haplotypes in the interleukin-4 gene are associated with chronic periodontitis in a Brazilian population. J. Periodontol. 2010, 81:392-402.
4. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357:539-545.
5. Beppu M., Ikebe T., Shirasuna K. The inhibitory effects of immunosuppressive factors, dexamethasone and interleukin-4, on NF-kappaB-mediated protease production by oral cancer. Biochim. Biophys. Acta 2002, 1586:11-22.
6. Blankenstein T. The role of tumor stroma in the interaction between tumor and immune system. Curr. Opin. Immunol. 2005, 17:180-186.
7. Chiang C.H., Tang Y.C., Lin M.W., Chung M.Y. Association between the IL-4 promoter polymorphisms and asthma or severity of hyperresponsiveness in Taiwanese. Respirology 2007, 12:42-48.
8. Elliott K., Fitzpatrick E., Hill D., Brown J., Adams S., et al. The -590C/T and -34C/T interleukin-4 promoter polymorphisms are not associated with atopic eczema in childhood. J. Allergy Clin. Immunol. 2001, 108:285-287.
9. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 2007, 18:581-592.
10. Gooch J.L., Lee A.V., Yee D. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Cancer Res. 1998, 58:4199-4205.
11. Gyan B.A., Goka B., Cvetkovic J.T., Kurtzhals J.L., Adabayeri V., et al. Allelic polymorphisms in the repeat and promoter regions of the interleukin-4 gene and malaria severity in Ghanaian children. Clin. Exp. Immunol. 2004, 138:145-150.
12. Hegab A.E., Sakamoto T., Saitoh W., Massoud H.H., Massoud H.M., et al. Polymorphisms of IL4, IL13, and ADRB2 genes in COPD. Chest 2004, 126:1832-1839.
13. Heward J.M., Nithiyananthan R., Allahabadia A., Gibson S., Franklyn J.A., Gough S.C. No association of an interleukin 4 gene promoter polymorphism with Graves' disease in the United Kingdom. J. Clin. Endocrinol. Metab. 2001, 86:3861-3863.
14. Holla L.I., Fassmann A., Augustin P., Halabala T., Znojil V., Vanek J. The association of interleukin-4 haplotypes with chronic periodontitis in a Czech population. J. Periodontol. 2008, 79:1927-1933.
15. Huang F.Y., Chang T.Y., Chen M.R., Lee H.C., Chiu N.C., et al. The -590 C/T and 8375 A/G interleukin-4 polymorphisms are not associated with Kawasaki disease in Taiwanese children. Hum. Immunol. 2008, 69:52-57.
16. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat. Rev. Cancer 2006, 6:392-401.
17. Kawashima T., Noguchi E., Arinami T., Yamakawa-Kobayashi K., Nakagawa H., et al. Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. J. Med. Genet. 1998, 35:502-504.
18. Kim Y.K., Pyo C.W., Choi H.B., Kim S.Y., Kim T.Y., Kim T.G. Associations of IL-2 and IL-4 gene polymorphisms with psoriasis in the Korean population. J. Dermatol. Sci. 2007, 48:133-139.
19. Lancaster A., Nelson M.P., Meyer D., Thomson G., Single R.M. PyPop: a software framework for population genomics: analyzing large-scale multi-locus genotype data. Pac. Symp. Biocomput. 2003, 514-525.
20. Landi S., Bottari F., Gemignani F., Gioia-Patricola L., Guino E., et al. Interleukin-4 and interleukin-4 receptor polymorphisms and colorectal cancer risk. Eur. J. Cancer 2007, 43:762-768.
21. Lee S.O., Lou W., Hou M., Onate S.A., Gao A.C. Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway. Oncogene 2003, 22:7981-7988.
22. Lee J.M., Yanagawa J., Peebles K.A., Sharma S., Mao J.T., Dubinett S.M. Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment. Crit. Rev. Oncol. Hematol. 2008, 66:208-217.
23. Lee S.O., Pinder E., Chun J.Y., Lou W., Sun M., Gao A.C. Interleukin-4 stimulates androgen-independent growth in LNCaP human prostate cancer cells. Prostate 2008, 68:85-91.
24. Li Y., Guo B., Zhang L., Han J., Wu B., Xiong H. Association between C-589T polymorphisms of interleukin-4 gene promoter and asthma: a meta-analysis. Respir. Med. 2008, 102:984-992.
25. Nunez C., Santiago J.L., Varade J., de la Calle H., Figueredo M.A., et al. IL4 in the 5q31 context: association studies of type 1 diabetes and rheumatoid arthritis in the Spanish population. Immunogenetics 2008, 60:19-23.
26. Olver S., Apte S., Baz A., Kienzle N. The duplicitous effects of interleukin 4 on tumour immunity: how can the same cytokine improve or impair control of tumour growth. Tissue Antigens 2007, 69:293-298.
27. Peebles K.A., Lee J.M., Mao J.T., Hazra S., Reckamp K.L., et al. Inflammation and lung carcinogenesis: applying findings in prevention and treatment. Expert. Rev. Anticancer. Ther. 2007, 7:1405-1421.
28. Rosenwasser L.J., Klemm D.J., Dresback J.K., Inamura H., Mascali J.J., et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin. Exp. Allergy 1995, 25(Suppl. 2):74-78. (discussion 95-6).
29. Rotar Ioana, Sorana D.Bolboaca, Daniel Muresan, Radu Popp, Marius Farcas, Felicia Petrisor, Cristina Butuza, Gabriela Caracostea, Florin Stamation The analysis of Genetic Polymorphis. The relationship between Interleukin-4 Polymorphisms and Intraepithelial Cervical Neoplasia. Applied Medical Informatics 2010, 43-52. 27 N. 3/2010.
30. Seder R.A., Paul W.E. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 1994, 12:635-673.
31. Shibata N., Ohnuma T., Kuerban B., Komatsu M., Baba H., Arai H. Genetic association between Akt1 polymorphisms and Alzheimer's disease in a Japanese population. Int. J. Alzheimers Dis. 2011, 762471.
32. Tangteerawatana P., Pichyangkul S., Hayano M., Kalambaheti T., Looareesuwan S., et al. Relative levels of IL4 and IFN-gamma in complicated malaria: association with IL4 polymorphism and peripheral parasitemia. Acta Trop. 2007, 101:258-265.
33. Tsezou A., Poultsides L., Kostopoulou F., Zintzaras E., Satra M., et al. Influence of interleukin 1alpha (IL-1alpha), IL-4, and IL-6 polymorphisms on genetic susceptibility to chronic osteomyelitis. Clin. Vaccine Immunol. 2008, 15:1888-1890.
34. Vairaktaris E., Yannopoulos A., Vassiliou S., Serefoglou Z., Vylliotis A., et al. Strong association of interleukin-4 (-590 C/T) polymorphism with increased risk for oral squamous cell carcinoma in Europeans. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2007, 104:796-802.
35. van Zandwijk N. Chemoprevention of lung cancer. Lung Cancer 2001, 34(Suppl. 3):S91-S94.
36. Varin A., Gordon S. Alternative activation of macrophages: immune function and cellular biology. Immunobiology 2009, 214(7):630-641. Epub 2009 Mar 5.
37. Vasse M., Paysant J., Soria J., Collet J.P., Vannier J.P., Soria C. Regulation of fibrinogen biosynthesis by cytokines, consequences on the vascular risk. Haemostasis 1996, 26(Suppl. 4):331-339.
38. Volpert O.V., Fong T., Koch A.E., Peterson J.D., Waltenbaugh C., et al. Inhibition of angiogenesis by interleukin 4. J. Exp. Med. 1998, 188:1039-1046.
39. Yannopoulos A., Nikiteas N., Chatzitheofylaktou A., Tsigris C. The (-590 C/T) polymorphism in the interleukin-4 gene is associated with increased risk for early stages of corolectal adenocarcinoma. In Vivo 2007, 21:1031-1035.
40. Zhu J., Ju X., Yan F., Qin C., Wang M., et al. Association of IL-4 -590 T>C polymorphism and risk of renal cell carcinoma in a Chinese population. Int. J. Immunogenet 2010, 37:459-465.